Rapid Micro Biosystems (NASDAQ:RPID) Upgraded by Wall Street Zen to "Hold" Rating

Key Points

• Rapid Micro Biosystems has been upgraded from a "sell" to a "hold" rating by Wall Street Zen, indicating a shift in analyst sentiment.
• Lake Street Capital initiated coverage with a "buy" rating and an $8.00 target price, contributing to a consensus rating of "Strong Buy" from analysts.
• Shares of Rapid Micro Biosystems experienced a notable range over the past year, with a 52-week low of $0.83 and a high of $4.50, highlighting its volatility in the market.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Saturday.

Separately, Lake Street Capital started coverage on shares of Rapid Micro Biosystems in a research report on Monday, July 28th. They set a "buy" rating and a $8.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Strong Buy" and an average target price of $8.00.

Rapid Micro Biosystems Stock Performance

Shares of RPID opened at $3.03 on Friday. The firm's 50-day simple moving average is $3.11 and its 200 day simple moving average is $2.93. Rapid Micro Biosystems has a 52 week low of $0.83 and a 52 week high of $4.50. The firm has a market cap of $133.96 million, a P/E ratio of -3.00 and a beta of 1.29.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.01). Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%.The business had revenue of $7.26 million for the quarter, compared to analyst estimates of $7.10 million. Rapid Micro Biosystems has set its FY 2025 guidance at EPS. As a group, equities analysts forecast that Rapid Micro Biosystems will post -1.1 earnings per share for the current year.

Insider Buying and Selling at Rapid Micro Biosystems

In other news, CEO Robert G. Jr. Spignesi sold 11,881 shares of the company's stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $3.32, for a total transaction of $39,444.92. Following the completion of the sale, the chief executive officer owned 970,550 shares of the company's stock, valued at approximately $3,222,226. This represents a 1.21% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders have sold 57,443 shares of company stock worth $195,952. Corporate insiders own 29.96% of the company's stock.

Institutional Trading of Rapid Micro Biosystems

A number of institutional investors and hedge funds have recently made changes to their positions in the company. ABG WTT Global Life Science Capital Partners GP Ltd lifted its holdings in shares of Rapid Micro Biosystems by 78.0% during the 1st quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company's stock worth $4,880,000 after acquiring an additional 810,000 shares during the period. Parkman Healthcare Partners LLC bought a new position in Rapid Micro Biosystems in the 1st quarter valued at approximately $1,942,000. Geode Capital Management LLC lifted its stake in Rapid Micro Biosystems by 1.6% in the 2nd quarter. Geode Capital Management LLC now owns 204,079 shares of the company's stock valued at $704,000 after purchasing an additional 3,143 shares during the last quarter. Informed Momentum Co LLC bought a new position in Rapid Micro Biosystems in the 1st quarter valued at approximately $467,000. Finally, Evernest Financial Advisors LLC bought a new position in Rapid Micro Biosystems in the 1st quarter valued at approximately $347,000. Institutional investors own 52.60% of the company's stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.